Nexafed
NDC Package 48964-112-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nexafed is a . Marketed by Acura Pharmaceuticals, Inc., this product is identified by NDC 48964-112 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
48964-112-24
Package Description
2 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
Product Code
48964-112
11-Digit Billing Format
48964011224
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA

Clinical Specifications

Proprietary Name
Nexafed
Dosage Form
-

Regulatory & Marketing

Labeler Name
Acura Pharmaceuticals, Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
07-10-2020
End Marketing Date
12-11-2021
Listing Expiration
12-11-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 48964-112-24 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet in 1 blister pack of Nexafed, labeled by Acura Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Acura Pharmaceuticals, Inc. on July 10, 2020. The current certification is valid through December 11, 2021.

How is this Acura Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 48964011224. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
48964-112-24
11-Digit CMS (5-4-2)
48964-0112-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.